SGX942
Paper
p62 at the Crossroads of Autophagy, Apoptosis, and Cancer
Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137(6),1001-4.
Paper
Predicting risk of chemotherapy-induced side effects in patients with colon cancer with single-nucleotide polymorphism (SNP) Bayesian networks (BNs)
Sonis ST, Schwartzbert LS, Walker MS, Weidner S, Alterovitz G. 2013. Predicting risk of chemotherapy-induced side effects in patients with colon cancer with single-nucleotide polymorphism (SNP) Bayesian networks. J Clin Oncol 2013;31 (4_suppl): Abstract 344.
Paper
Abstract P1-15-12: Single Nucleotide Polymorphism (SNP) Bayesian networks (BNs) Predict Risk of Chemotherapy-Induced Side Effects in Patients with Breast Cancer Receiving Dose Dense (DD) Doxorubicin/Cyclophosphamide Plus Paclitaxel (AC+T)
Schwartzberg LS, Sonis ST, Walker MS, Weidner SM, Alterovitz G. Single Nucleotide Polymorphism (SNP) Bayesian networks (BNs) Predict Risk of Chemotherapy-Induced Side Effects in Patients with Breast Cancer Receiving Dose Dense (DD) Doxorubicin/Cyclophosphamide Plus Paclitaxel (AC+T). Cancer Res. 2012;72 (24 Suppl): Abstract nr P1-15-12.
Paper
SNP-Based Bayesian networks define OM risk in patients receiving somatotoxic conditioning regimens for autologous hematopoietic stem cell transplantation
Sonis S, Antin J, Tedaldi M, Alterovitz G, SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients. Oral Dis. 19(7):721-7.
Paper
Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-d-glutamyl-l-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis
Alterovitz G, Tuthill C, Rios I, Modelska K, Sonis S. 2011. Personalized medicine for mucositis: Bayesian networks identify unique gene clusters, which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced OM. Oral Oncol. 2011;47:951-5.
Paper
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines
Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Annals of Oncology 22. 2011; Supplement 6: vi78–vi84.
Paper
New thoughts on the initiation of mucositis
Sonis ST. New thoughts on the initiation of mucositis. Oral Dis. 2010;16,597-600.
Paper
Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome 1 and Histone Deacetylase 6
Into T, Inomata M, Niida S, Murakami Y, Shibata K. Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome-1 and Histone Deacetylase 6. J Biol Chem. 2010;285(46),35759-35769
Poster
Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide
Kielczewska A, Yu HB, Rozek A, Takenaka S, Li Y, Guarna MM, North JR, Foster LJ, Finlay BB, Donini O. Sequestosome-1 / p62 is the key intracellular target of innate defense regulator peptide. Poster presentation at Keystone Symposium on The Macrophage: The intersection of Pathogenic & Protective Inflammation. 2010.
Poster
Reduced Infection and Mucositis in Chemotherapy-Treated Animals Following Innate Defense Modulation Using a Novel Drug Candidate
Donini O, Watkins BA, Palardy J, Opal S, Sonis S, Abrams MJ, North JR. Reduced Infection and Mucositis in Chemotherapy-Treated Animals Following Innate Defense Modulation Using a Novel Drug Candidate. 2010. Blood (ASH Annual Meeting Abstracts) 2010; 116:3781